PBM Rebates In Medicaid “Pharmacy Plus” Plan Should Go To States – NACDS
Executive Summary
Prescription drug rebates obtained by pharmacy benefit management companies as part of administering the Medicaid "Pharmacy Plus" waiver program should be turned over to the states, the National Association of Chain Drug Stores told the Centers for Medicare & Medicaid Services
You may also be interested in...
White House Medicare Rx Plans Include $77 Bil. Medicaid Expansion
The White House is proposing expanded drug coverage for seniors through state Medicaid programs as part of a package of interim approaches toward a comprehensive Medicare prescription drug benefit
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA Skin Infections Guidance Spurs Debate On Endpoint Relevance
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials